2012•Unpublished venueRequires access

CONVERT: Study Of Patients With Pulmonary Arterial Hypertension Treated With Iloprost (Inhalation), Evaluating Inhalation Times, Compliance, Safety, And Tolerability When Converting From The Iloprost Inhalation Solution 10 µg/mL To The 20 µg/mL With The I-neb® AAD® System

Sean M. Studer, Steven M. Kawut, Wade W. Benton, J. Wesley MCCONNELL, Kimberly Hobbs, Desilu Villaneuva, Arunabh Talwar, Harold I. Palevsky

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Iloprost, Inhalation, Tolerability, Medicine, Anesthesia, Internal medicine, Adverse effect, Prostacyclin

Back to paper search Browse research topics Original source

CONVERT: Study Of Patients With Pulmonary Arterial Hypertension Treated With Iloprost (Inhalation), Evaluating Inhalation Times, Compliance, Safety, And Tolerability When Converting From The Iloprost Inhalation Solution 10 µg/mL To The 20 µg/mL With The I-neb® AAD® System — Research Paper | ScholarLens